Triple-negative breast cancer (TNBC) is a form of endocrine resistant breast cancer that is significant for a lack of targetable receptors ER, progesterone receptors (PR), and human epidermal growth factor receptor 2 (HER2) [7]. This evidence concerns the gene PGR and triple-negative breast carcinoma.